These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 21892124)

  • 1. Antibiotic treatment of Escherichia coli O157 infection and the risk of hemolytic uremic syndrome, Minnesota.
    Smith KE; Wilker PR; Reiter PL; Hedican EB; Bender JB; Hedberg CW
    Pediatr Infect Dis J; 2012 Jan; 31(1):37-41. PubMed ID: 21892124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strength of the association between antibiotic use and hemolytic uremic syndrome following Escherichia coli O157:H7 infection varies with case definition.
    Tarr GAM; Oltean HN; Phipps AI; Rabinowitz P; Tarr PI
    Int J Med Microbiol; 2018 Oct; 308(7):921-926. PubMed ID: 30257808
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
    Wong CS; Jelacic S; Habeeb RL; Watkins SL; Tarr PI
    N Engl J Med; 2000 Jun; 342(26):1930-6. PubMed ID: 10874060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemolytic uremic syndrome and death in persons with Escherichia coli O157:H7 infection, foodborne diseases active surveillance network sites, 2000-2006.
    Gould LH; Demma L; Jones TF; Hurd S; Vugia DJ; Smith K; Shiferaw B; Segler S; Palmer A; Zansky S; Griffin PM
    Clin Infect Dis; 2009 Nov; 49(10):1480-5. PubMed ID: 19827953
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemolytic Uremic Syndrome After an Escherichia coli O111 Outbreak.
    Piercefield EW; Bradley KK; Coffman RL; Mallonee SM
    Arch Intern Med; 2010 Oct; 170(18):1656-63. PubMed ID: 20937925
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Risk of hemolytic uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 enteritis: a meta-analysis.
    Safdar N; Said A; Gangnon RE; Maki DG
    JAMA; 2002 Aug; 288(8):996-1001. PubMed ID: 12190370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The central Scotland Escherichia coli O157:H7 outbreak: risk factors for the hemolytic uremic syndrome and death among hospitalized patients.
    Dundas S; Todd WT; Stewart AI; Murdoch PS; Chaudhuri AK; Hutchinson SJ
    Clin Infect Dis; 2001 Oct; 33(7):923-31. PubMed ID: 11528561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Infections in pediatric postdiarrheal hemolytic uremic syndrome: factors associated with identifying shiga toxin-producing Escherichia coli.
    Mody RK; Luna-Gierke RE; Jones TF; Comstock N; Hurd S; Scheftel J; Lathrop S; Smith G; Palmer A; Strockbine N; Talkington D; Mahon BE; Hoekstra RM; Griffin PM
    Arch Pediatr Adolesc Med; 2012 Oct; 166(10):902-9. PubMed ID: 22869280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Desperately seeking diarrhoea: outbreak of haemolytic uraemic syndrome caused by emerging sorbitol-fermenting shiga toxin-producing Escherichia coli O157:H-, Germany, 2009.
    Nielsen S; Frank C; Fruth A; Spode A; Prager R; Graff A; Plenge-Bönig A; Loos S; Lütgehetmann M; Kemper MJ; Müller-Wiefel DE; Werber D
    Zoonoses Public Health; 2011 Dec; 58(8):567-72. PubMed ID: 21824358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of hemolytic uremic syndrome in children during a large outbreak of Escherichia coli O157:H7 infections.
    Bell BP; Griffin PM; Lozano P; Christie DL; Kobayashi JM; Tarr PI
    Pediatrics; 1997 Jul; 100(1):E12. PubMed ID: 9200386
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antimicrobial and antimotility agent use in persons with shiga toxin-producing Escherichia coli O157 infection in FoodNet Sites.
    Nelson JM; Griffin PM; Jones TF; Smith KE; Scallan E
    Clin Infect Dis; 2011 May; 52(9):1130-2. PubMed ID: 21467017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.
    Hedican EB; Medus C; Besser JM; Juni BA; Koziol B; Taylor C; Smith KE
    Clin Infect Dis; 2009 Aug; 49(3):358-64. PubMed ID: 19548834
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The epidemiology and clinical aspects of the hemolytic uremic syndrome in Minnesota.
    Martin DL; MacDonald KL; White KE; Soler JT; Osterholm MT
    N Engl J Med; 1990 Oct; 323(17):1161-7. PubMed ID: 2215593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk factors for the hemolytic uremic syndrome in children infected with Escherichia coli O157:H7: a multivariable analysis.
    Wong CS; Mooney JC; Brandt JR; Staples AO; Jelacic S; Boster DR; Watkins SL; Tarr PI
    Clin Infect Dis; 2012 Jul; 55(1):33-41. PubMed ID: 22431799
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of the hemolytic-uremic syndrome after antibiotic treatment of Escherichia coli O157:H7 infections.
    Aragón T; Fernyak S; Reiter R
    N Engl J Med; 2000 Oct; 343(17):1271-2; author reply 1272-3. PubMed ID: 11183357
    [No Abstract]   [Full Text] [Related]  

  • 17. Escherichia coli O157 fails to induce a long-lasting lipopolysaccharide-specific, measurable humoral immune response in children with hemolytic-uremic syndrome.
    Ludwig K; Bitzan M; Bobrowski C; Müller-Wiefel DE
    J Infect Dis; 2002 Aug; 186(4):566-9. PubMed ID: 12195387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating granulocyte colony-stimulating factor, C-X-C, and C-C chemokines in children with Escherichia coli O157:H7 associated hemolytic uremic syndrome.
    Proulx F; Toledano B; Phan V; Clermont MJ; Mariscalco MM; Seidman EG
    Pediatr Res; 2002 Dec; 52(6):928-34. PubMed ID: 12438672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Endemic Esherichia coil O157:H7 infections and hemolytic-uremic syndrome in Oklahoma, 2002-2005.
    Karpac CA; Lee A; Kunnel BS; Bamgbola OF; Vesely SK; George JN
    J Okla State Med Assoc; 2007 Nov; 100(11):429-33. PubMed ID: 18183860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Soluble Fas and soluble Fas-ligand in children with Escherichia coli O157:H7-associated hemolytic uremic syndrome.
    Masri C; Proulx F; Toledano B; Clermont MJ; Mariscalco MM; Seidman EG; Carcillo J
    Am J Kidney Dis; 2000 Oct; 36(4):687-94. PubMed ID: 11007669
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.